Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $211,931 - $269,964
-2,215 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $842,830 - $1.47 Million
-9,606 Reduced 81.26%
2,215 $221,000
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $42,706 - $55,803
-363 Reduced 2.98%
11,821 $1.77 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $405,207 - $463,667
3,237 Added 36.18%
12,184 $1.56 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $1.12 Million - $1.29 Million
8,947 New
8,947 $1.28 Million
Q1 2019

May 20, 2019

SELL
$121.81 - $142.95 $471,161 - $552,930
-3,868 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $448,455 - $644,950
3,868 New
3,868 $479,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.1B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.